CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
69 hedge funds and large institutions have $1.3B invested in China Biologic Products Holdings, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
30% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 27
Holders
69
Holding in Top 10
7
Calls
$22.5M
Puts
$9.87M
Top Buyers
| 1 | +$32.3M | |
| 2 | +$20.3M | |
| 3 | +$9.05M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$6.02M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$4.97M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$19.8M | |
| 3 | -$17M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$16.2M |
| 5 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
-$14.8M |